Schedule poster discussions

Poster topic

Discussion date/time

 Abstracts

Andrology

Monday 15 June, from 13:00 to 14:00

  • P-024 Comparison of pregnancy rates with intrauterine insemination with different abnormal semen parameters and all combinations of those parameters by the 2010 World Health Organization guidelines - A. Kuriya
  • P-028 Seminal Transforming growth factor ß1, Insulin-like growth factor I and Epidermal growth factor Status in male idiopathic infertility - S. Jallad
  • P-060 Sperm DNA damage should be considered in infertile couples due to production of high inflammatory cytokines via Toll Like Receptores - Z. Zandieh
  • P-066 Titanium dioxide nanoparticles reduce human sperm DNA stability - L. Rocco

Early Pregnancy

Monday 15 June, from 13:00 to 14:00

  • P-166 Crucial role of hypoxia inducible factor 2alpha in the pregnant uterus - L. Matsumoto
  • P-168 Peri-conceptional Progesterone treatment in women with unexplained recurrent miscarriage, A randomized double-blind controlled trial - H. Al-Inany

Embryology

Monday 15 June, from 13:00 to 14:00

  • P-176 Comparison of dynamic culture and dynamic culture with specialized surfaces culture method in poor responders - Y. Hur
  • P-192 Ruffling" phenomenon prior to the first cleavage observed by high-resolution time-lapse cinematography and its impacts on human embryonic development in vitro" - K. Yumoto
  • P-209 A historical cohort study to investigate the relation between blastomere survival and mitosis resumption in frozen-thawed embryo's and ongoing pregnancy - J. Diaz de Pool
  • P-276 Which parameters affect the incidence of monozygotic twin pregnancies after single embryo transfer? - I. Mateizel
  • P-296 S-Biopsy: a simplified, less invasive embryo biopsy technique for day 3 preimplantational genetic screening (PGS) - L. Cedillo García Lascurain

Endometriosis/Endometrium

Monday 15 June, from 13:00 to 14:00

  • P-313 Endometrial growth inhibition by natural compounds evaluated as new therapeutic agents for endometriosis - M. Gabriela
  • P-360 Galectin-1 is over-expressed in endometriotic lesions from patients with minimal to mild endometriosis and promotes eutopic endometrial stromal cell proliferation - M. Gabriela
  • P-361 Human embryo co-culture up to day 14 on a two-dimension in vitro model - A. Aberkane
  • P-372 Soft microenvironments inactivate the fibrotic phenotype of endometriotic stromal cells - S. Matsuzaki

Female (in)fertility

Monday 15 June, from 13:00 to 14:00

  • P-397 Direct ovarian stimulation (DOS) by intra-ovarian injection of corifollitropin-a for the patients with poor ovarian response in IVF-ET program - H.C. Kwon 
  • P-421 Association between uterine perfusion and inherited thrombophilia in patients with unexplained infertility - H.A. Selman

Male and female fertility preservation

Monday 15 June, from 13:00 to 14:00

  • P-451 Safety assessment of cryopreserved ovarian tissue transplantation in breast cancer patients by molecular techniques and in vivo study - E. Novella-Maestre
  • P-486 Letrozole co-treatment does not jeopardize effectiveness of controlled ovarian hyperstimulation for oocyte vitrification in breast cancer patients - C.G. Ceballos Garcia
  • P-490 Anti Mullerian Hormone (AMH) co-treatment to prevent chemotherapy-induced follicle activation and loss - R. Rosenes

Psychology and Counselling

Tuesday 16 June, from 13:00 to 14:00

  • P-531 The ART of communication: results from an international needs assessment in Assisted Reproductive Technologies - S.M. Hayes
  • P-539 Corticotropin-Releasing Hormone and postpartum depression: a longitudinal study - S. Iliadis

Reproductive (epi)genetics

Tuesday 16 June, from 13:00 to 14:00

  • P-613 Comparison of the live birth rate between preimplantation genetic diagnosis and natural conception in patients with recurrent pregnancy loss associated with translocation - S. Ikuma
  • P-622 An association between thrombophilias and pregnancy loss: should we test? - S. Bristow
  • P-631 Endogenous retrotransposon expression and de novo retrotransposition events after incorporation of exogenous retroelements in human spermatozoa - L. Lazaros
  • P-646 Preimplantation genetic diagnosis (PGD) for inherited disorders using single nucleotide polymorphism (SNP) arrays: clinical outcomes of 100 cycles with transferable embryos - A. Jordan

Reproductive Endocrinology

Monday 15 June, from 13:00 to 14:00

  • P-673 Use of dual trigger with gonadotropin-releasing hormone agonist (GnRH-a) and human chorionic gonadotropin (hCG) to optimize oocyte recovery rates and IVF results - M.J. Iñarra Velasco
  • P-715 Ovarian reserve and response risk categorisation using the new automated AMH assay produced by Roche® - C. Fairbairn
  • P-741 Exercise training reduces acute physiological severity of menopausal hot flushes - T. Bailey
  • P-742 The contribution of FSH receptor polymorphism on ovarian response and treatment efficiency following stimulation with FE 999049, a recombinant FSH from a human cell-line - J.C. Arce

Reproductive epidemiology, socio-cultural aspects and health economy

Tuesday 16 June, from 13:00 to 14:00

  • P-745 A prospective randomized controlled study (RCT) depicting favourable IVF-ICSI outcomes following anti-tubercular treatment on the sole basis of abnormal hysteroscopic findings - A. Jindal
  • P-751 Publication bias in the field of subfertility - S. Lensen
  • P-753 Pre-treatment serum vitamin D levels and fertilization rates among women undergoing assisted reproduction - L. Abadia

Reproductive Surgery

Tuesday 16 June, from 13:00 to 14:00

  • P-772 The outcome of “conservative debulking surgery” in infertile women with uterine adenomyosis - S.H. Yoon
  • P-777 Reliability of the ESHRE/ESGE and ASRM classification systems of uterine congenital malformations - A. Ludwin
  • P-780 Diagnosis, Management, and Outcome of Obstructed Hemivagina and Ipsilateral Renal Agenesis (OHVIRA syndrome) in 16 Cases - F. Gungor Ugurlucan

Safety and quality of ART therapies

Tuesday 16 June, from 13:00 to 14:00

 
  • P-571 The role of Cyclin D1 in the development of Borderline ovarian tumors after ovarian hyperstimulation - G. Di Luigi
  • P-576 GnRH antagonist administered twice the day before hCG trigger, may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes - I. Prapas

Stem Cells

Tuesday 16 June, from 13:00 to 14:00


  • P-790 Comparison of differentiation potential and oocyte regeneration from ovarian surface epithelium-derived ovarian stem cells between young and aged female mice - B.S. Joo
  • P-794 Is skewed X chromosome inactivation in human embryonic stem cells driven by a culture advantage? - M. Geens